NCT03396159 is a NA clinical trial of mini fluid challenge in Liver Transplantation, sponsored by Kasr El Aini Hospital.

Who is sponsoring NCT03396159?

NCT03396159 is sponsored by Kasr El Aini Hospital.

What drugs are being tested in NCT03396159?

Interventions in NCT03396159: mini fluid challenge.

What condition does NCT03396159 study?

NCT03396159 studies Liver Transplantation.

Is NCT03396159 still recruiting?

NCT03396159 is currently completed. Last updated 23 July 2018.

Last reviewed 2018-07-23 · How we verify

NCT03396159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity of Mini Fluid Challenge Post Liver Transplantation

Completed NA Last updated 23 July 2018

What this trial tests

NA trial testing mini fluid challenge in Liver Transplantation in 30 participants. Completed in 20 May 2018.

Timeline

30 January 2018

Primary endpoint
20 May 2018

20 May 2018

Quick facts

Lead sponsor	Kasr El Aini Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	30 January 2018
Primary completion	20 May 2018
Estimated completion	20 May 2018
Sites	1 location across Egypt

Drugs / interventions tested

mini fluid challenge

Conditions studied

Liver Transplantation — all drugs for Liver Transplantation →

Sponsor

Kasr El Aini Hospital

Who can join

18 and older, any sex, with Liver Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

our study aim to assess the validity of using mini fluid challenge to assess the volaemic status of patients after liver transplantation

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Validity of mini-fluid challenge for predicting fluid responsiveness following liver transplantation.
Mukhtar A, Awad M, Elayashy M, Hussein A, et al · · 2019 · cited 6× · PMID 30987597 · DOI 10.1186/s12871-019-0728-4
Validity of Mini-Fluid Challenge for Predicting Fluid Responsiveness Following Liver Transplantation
Mukhtar A, Awad M, Elayashy M, Hussein A, et al · · 2019 · DOI 10.21203/rs.2.415/v3

Verify or expand the search:

Other recruiting trials for Liver Transplantation

Currently open trials in the same condition.

NCT07157631 — Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial · NA · recruiting
NCT07123740 — Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors · NA · recruiting
NCT06717919 — HOPE Against Cancer Recurrence in HCC · Phase 4 · recruiting
NCT06868589 — Reducing Pain With Methadone and Ketamine in Liver Transplant · Phase 4 · active not recruiting
NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

NCT07438652 — Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT · NA · recruiting
NCT07488039 — Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss · NA · recruiting
NCT07274280 — Comparative Evaluation of Ambu AuraGain, LarySeal Pro and I-gel in Pediatric Airway Management for Day-Case Surgery Unde · NA · not yet recruiting
NCT07348146 — Hand-Sewn vs. Stapled Anastomosis in SADI-S: Early Postoperative Complications. · NA · enrolling by invitation
NCT07077265 — Comparing Two Different Norepinephrine Infusion Rates for Prophylaxis Against Spinal-induced Hypotension in Elderly · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03396159 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kasr El Aini Hospital
Last refreshed: 23 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03396159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing